Company on track for first subject treated in pivotal, adaptive Phase 3 clinical trial (the "MIRACLE" trial) in the first quarter of 2025 Trial designed for possible accelerated approval of Annamycin ...
The mission of Pratt Institute’s Human Research Subjects Committee / Institutional Review Board (IRB) is to ensure quality research involving human subjects conducted under the auspices of the ...
HUMACAO, PR and NEW YORK, NY / ACCESS Newswire / April 29, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery ...
Clearmind Medicine Inc., a clinical-stage biotech company focused on psychedelic-derived therapeutics, has announced the receipt of Institutional Review Board approval for its Phase I/IIa clinical ...
8d
IRB & ICF Approval Simplified: 5 Key Considerations and Mistakes, Upcoming Webinar Hosted by Xtalks
In this practical discussion, the featured speakers will share lessons learned from hundreds of submissions and real-world examples of what can make or break ethics reviews, particularly around ...
All human subjects research connected with members of the Smith College community (either as researchers or study participants) must be reviewed and approved by the IRB prior to the initiation of the ...
* Oncosil receives institutional review board approval from md anderson cancer center for pancreatic clinical study programme Source text for Eikon: Further company coverage: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback